Pharmacology, Toxicology and Pharmaceutical Science
4-Aminopyridine
15%
Acinetobacter Baumannii
28%
Adalimumab
18%
Adverse Event
59%
Amentoflavone
15%
Anti-Inflammatory Drug
26%
Antibiotic Prophylaxis
16%
Antibiotics
80%
Antiinfective Agent
36%
Antimicrobial Resistance
73%
Antioxidant
24%
Antithrombocytic Agent
15%
Cohort Study
19%
Community Pharmacy
16%
Comorbidity
36%
COVID-19 Vaccine
38%
Cross-Sectional Study
60%
Diabetes Mellitus
100%
Diseases
43%
Drug Interaction
30%
Drug Resistance
20%
Escherichia coli
21%
Etanercept
20%
FDA Adverse Event Reporting System
29%
Glycoside
15%
Hemoglobin A1c
25%
Hydroxychloroquine
15%
Infection
45%
Inflammation
17%
Inflammatory Arthritis
21%
Klebsiella pneumoniae
18%
Methotrexate
15%
Orphan Drug
15%
Pandemic
16%
Pharmacotherapy
39%
Pharmacovigilance
21%
Polypharmacy
30%
Prevalence
53%
Protective Agent
17%
Pseudomonas aeruginosa
18%
Retrospective Study
19%
Rheumatoid Arthritis
21%
Side Effect
37%
Staphylococcus aureus
15%
Surgical Infection
33%
Surgical Prophylaxis
33%
Transcription Factor Nrf2
30%
Ubidecarenone
15%
Ustekinumab
15%
Warfarin
30%
Nursing and Health Professions
Ampicillin
7%
Antiinfective Agent
18%
Antimicrobial Resistance
30%
Antimicrobial Stewardship
15%
Artificial Respiration
7%
Chronic Disease
15%
Cohort Analysis
23%
Colistimethate
15%
Combination Therapy
15%
Comorbidity
11%
Confidence Interval
20%
Congestive Heart Failure
15%
Counseling
6%
Cross-Sectional Study
76%
Daptomycin
7%
Diabetes Mellitus
34%
Disease Duration
7%
Diseases
26%
Drug Therapy
19%
Fampridine
15%
Food and Drug Administration
15%
Health Care
9%
Health Care Cost
15%
Health Care Personnel
42%
Healthcare System
7%
Hemoglobin A1c
8%
Hospital Discharge
7%
Household
15%
Infection
5%
Intensive Care Unit
6%
Logistic Regression Analysis
10%
Medication Compliance
11%
Multiple Sclerosis
5%
Odds Ratio
22%
Patient Care
15%
Patient Compliance
18%
Patient with Diabetes
9%
Perioperative
15%
Pharmacy Student
15%
Polypharmacy
21%
Practice Guideline
6%
Prevalence
16%
Primary Health Care
32%
Quality of Life
15%
Socioeconomic Status
6%
Surgical Infection
15%
Telemedicine
38%
Tertiary Care Center
30%
Univariate Analysis
7%
Medicine and Dentistry
Acinetobacter
15%
Acinetobacter Baumannii
15%
Antibiogram
5%
Antibiotic Resistance
5%
Antibiotics
5%
Antifungal Agent
7%
Antiinfective Agent
7%
Autosomal Recessive Inheritance
5%
Cardiovascular System
15%
Cefalotin
7%
Chronic Disease
15%
Colistimethate
5%
Combination Therapy
15%
Comorbidity
9%
COVID-19 Vaccination
15%
Culture Conversion
11%
Diabetes Mellitus
30%
Diabetic Retinopathy
15%
Disease
5%
Disease Duration
6%
Diseases
13%
Drug Resistant Tuberculosis
15%
Drug Therapy
18%
Foreign Body
7%
Gram-Negative Bacteria
7%
Hemoglobin A1c
7%
Klebsiella pneumoniae
15%
Metabolic Disorder
5%
Multivariate Analysis
5%
Nitrofurantoin
7%
Pathogen
5%
Patient Care
23%
Physical Disease by Body Function
5%
Pneumomediastinum
15%
Pneumothorax
15%
Primary Health Care
15%
Quality of Life
15%
Rare Disease
5%
Sputum Culture
11%
Sputum Smear
15%
Systematic Review
15%
Tertiary Care
18%
Univariate Analysis
8%
Vaccine Hesitancy
15%
